The Latest Breaking News from FDA

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug

The facts alone make for compelling viewing, but without access to all the main players it feels incomplete

Trish Webster lost 16 kilograms but the consequences were allegedly lethal

A new study finds that hormonal contraceptive pills may affect parts of the brain that deal with fear.

Policies inspired by that exaggerated threat continue to undermine the harm-reducing potential of e-cigarettes.

The ongoing investigation now entails reports of seven "adverse events" that took place from Oct. 17 through Nov. 1

Biotech major Biogen (BIIB) will report its third-quarter results on November 8. Its EPS and revenue are expected to decline year-over-year. However, the FDA approvals for new drugs received by the company this year will likely support its long-term growth. Let’s discuss the potential road ahead for the stock….

More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies

The DAIRY PRIDE Act says it wants to protect consumers. In reality, it's trying to protect dairy farmers from economic competition.

We need to address the unnecessary and wasteful Medsafe approval for tried and tested drugs by much bigger regulatory authorities abroad, argues Dr Eric Crampton

RSV kills 300 kids and thousands of seniors every year. But a new treatment is already facing shortages